EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comparative analysis of Tet2 catalytic-deficient and knockout bone marrow over time

Julio C Flores, Kyoko Ito, Cheng-Yen Huang, Qin Tang, Chie Yanase, Keisuke Ito, Meelad M Dawlaty

Experimental Hematology · 2023-08 · 124 · 45-55.e2

DOI: 10.1016/j.exphem.2023.05.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Hematology, 2023-08. Verfasst von Julio C Flores und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY; Department…. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Myelodysplastic Syndromes, Hematologic Diseases, Dioxygenases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TET2 is a member of the Ten-eleven translocation (Tet) family of DNA dioxygenases that regulate gene expression by promoting DNA demethylation (enzymatic activity) and partnering with chromatin regulatory complexes (nonenzymatic functions). TET2 is highly expressed in the hematopoietic lineage, where its molecular functions are the subject of continuous investigations because of the prevalence of TET2 mutations in hematologic malignancies. Previously, we have implicated Tet2 catalytic and noncatalytic functions in the regulation of myeloid and lymphoid lineages, respectively. However, the impact of these functions of Tet2 on hematopoiesis as the bone marrow ages remains unclear. Here, we conducted comparative transplantations and transcriptomic analyses of 3-, 6-, 9-, and 12-month-old Tet2 catalytic mutant (Mut) and knockout (KO) bone marrow. Tet2 Mut bone marrow of all ages exclusively caused hematopoietic disorders of the myeloid lineage. In contrast, young Tet2 KO bone marrow developed both lymphoid and myeloid diseases, whereas older Tet2 KO bone marrow predominantly elicited myeloid disorders with shorter latency than age-matched Tet2 Mut bone marrow. We identified robust gene dysregulation in Tet2 KO Lin- cells at 6 months that involved lymphoma and myelodysplastic syndrome and/or leukemia-causing genes, many of which were hypermethylated early in life. There was a shift from lymphoid to myeloid gene deregulation in Tet2 KO Lin- cells with age, underpinning the higher incidence of myeloid diseases. These findings expand on the dynamic regulation of bone marrow by Tet2 and show that its catalytic-dependent and -independent roles have distinct impacts on myeloid and lymphoid lineages with age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsMyelodysplastic SyndromesHematologic DiseasesDioxygenasesHumansInfantBone MarrowHematopoiesisMutation

Substanzen

Dioxygenases

Autor:innen und Institutionen

  • Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY; Department of Genetics, Albert Einstein College of Medicine, Bronx, NY; Departme…
  • Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY; Depa…
  • Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY.

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • NCI NIH HHS
  • National Heart, Lung, and Blood Institute
  • Leukemia and Lymphoma Society
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Flores, J. C., Ito, K., Huang, C. Y., Tang, Q., Yanase, C., Ito, K., & Dawlaty, M. M. (2023). Comparative analysis of Tet2 catalytic-deficient and knockout bone marrow over time. Experimental Hematology, 124, 45-55.e2. https://doi.org/10.1016/j.exphem.2023.05.004

Vancouver

Flores JC, Ito K, Huang CY, Tang Q, Yanase C, Ito K, et al. Comparative analysis of Tet2 catalytic-deficient and knockout bone marrow over time. Experimental Hematology. 2023;124:45-55.e2. doi:10.1016/j.exphem.2023.05.004

BibTeX
@article{Flores2023,
  author = {Flores, Julio C and Ito, Kyoko and Huang, Cheng-Yen and Tang, Qin and Yanase, Chie and Ito, Keisuke and Dawlaty, Meelad M},
  title = {Comparative analysis of Tet2 catalytic-deficient and knockout bone marrow over time},
  journal = {Experimental Hematology},
  year = {2023},
  volume = {124},
  pages = {45--55.e2},
  doi = {10.1016/j.exphem.2023.05.004}
}
Kostenlos starten →